See Detailed Description
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009179/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study was designed to evaluate if subjects who took 600 mg of abacavir and 300 mg of
lamivudine once-daily as a single tablet were just as likely to have adverse events compared
to subjects who took 300 mg of abacavir and 150 mg of lamivudine administered as separate
tablets twice-daily.
提供机构：
Vivli
创建时间：
2023-08-15
